title: Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?
abstract: Approximately 10 to 15% of tuberculosis (TB) cases in India are estimated to have extrapulmonary disease, and due to a lack of diagnostic means, they often remain untreated. The early detection of Mycobacterium tuberculosis and multidrug resistance is a priority in TB diagnosis to improve the successful treatment rate of TB and reduce transmission. The Xpert MTB/RIF (Xpert) test, recently endorsed by the World Health Organization for the detection of pulmonary TB, was evaluated to test its utility in 547 patients with suspected extrapulmonary tuberculosis. Five hundred forty-seven extrapulmonary specimens were split and processed simultaneously for both culture (solid and liquid) and Xpert testing. For culture, the sensitivity was low, 53% (150/283 specimens). Xpert sensitivity and specificity results were assessed in comparison to a composite reference standard made up of smear and culture results and clinical, radiological, and histological findings. The sensitivity of the Xpert assay was 81% (228/283 specimens) (64% [89/138] for smear-negative cases and 96% [139/145] for smear-positive cases), with a specificity of 99.6%. The sensitivity was found to be high for the majority of specimen types (63 to 100%) except for cerebrospinal fluid, the sensitivity of which was 29% (2/7 specimens). The Xpert test correctly identified 98% of phenotypic rifampin (RIF)-resistant cases and 94% of phenotypic RIF-susceptible cases. Sequencing of the 6 discrepant samples resolved 3 of them, resulting in an increased specificity of 98%. In conclusion, the results of this study suggest that the Xpert test also shows good potential for the diagnosis of extrapulmonary TB and that its ease of use makes it applicable for countries where TB is endemic.
authors: PD Hinduja National Hospital and Medical Research Centre, Mahim, Mumbai, India.
authors: Viral
authors: V
authors: Vadwai
authors: Catharina
authors: C
authors: Boehme
authors: Pamela
authors: P
authors: Nabeta
authors: Anjali
authors: A
authors: Shetty
authors: David
authors: D
authors: Alland
authors: Camilla
authors: C
authors: Rodrigues
references: J Clin Microbiol. 2010 Jan;48(1):229-37
references: 19864480
references: Am J Respir Crit Care Med. 1997 May;155(5):1497-8
references: 9154847
references: J Clin Microbiol. 2000 Dec;38(12):4382-6
references: 11101568
references: Clin Vaccine Immunol. 2008 Jan;15(1):106-14
references: 17989336
references: Future Microbiol. 2008 Feb;3(1):1-4
references: 18230027
references: Stat Med. 1999 Nov 30;18(22):2987-3003
references: 10544302
references: BMC Infect Dis. 2004 Feb 23;4:6
references: 15102325
references: Clin Chem. 2003 Jan;49(1):1-6
references: 12507953
references: Int J Tuberc Lung Dis. 2007 Nov;11(11):1166-76
references: 17958977
references: N Engl J Med. 2010 Sep 9;363(11):1005-15
references: 20825313
references: BMC Med Res Methodol. 2006 Jul 12;6:31
references: 16836745
references: PLoS Med. 2008 Jul 22;5(7):e156
references: 18651788
references: J Clin Microbiol. 2010 Oct;48(10):3551-7
references: 20720033
references: J Clin Microbiol. 2010 Jul;48(7):2495-501
references: 20504986
references: J Clin Microbiol. 2007 Aug;45(8):2635-40
references: 17537937